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ABSTRACT
Introduction: Chlamydia is a key health concern with
high economic and social costs. There were over
200 000 chlamydia diagnoses made in England in
2015. The burden of chlamydia is greatest among
young people where the highest prevalence rates are
found. Annual testing for sexually active young
people is recommended; however, many of those at
risk do not receive testing. General practice has been
identified as an ideal setting for testing, yet efforts
to increase testing in this setting have not been
effective. One theoretical model which may provide
insight into the underpinnings of chlamydia testing
is the Capability, Opportunity and Motivation Model
of Behaviour (COM-B model). The aim of this
systematic review is to: (1) identify barriers and
facilitators to chlamydia testing for young people in
general practice and (2) use a theoretical model to
conduct a behavioural analysis of chlamydia testing
behaviour.
Methods and analysis: Qualitative, quantitative
and mixed methods studies published after 2000
will be included. Seven databases (MEDLINE,
PubMed, EMBASE, Informit, PsycInfo, Scopus, Web
of Science) will be searched to identify peer-
reviewed publications which examined barriers and
facilitators to chlamydia testing in general practice.
Risk of bias will be assessed using the Critical
Appraisal Skills Programme. Data regarding study
design and key findings will be extracted. The data
will be analysed using thematic analysis and the
resultant factors will be mapped onto the
COM-B model components. All findings will be
reported in accordance with the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
guidelines.
Ethics and dissemination: Ethical approval is not
required. The results will be disseminated via
submission for publication to a peer-review journal
when complete and for presentation at national and
international conferences. The review findings will
be used to inform the development of interventions
to facilitate effective and efficient chlamydia testing
in general practice.
INTRODUCTION
Chlamydia is a key public health concern
with great economic and social costs. There
were 200 288 chlamydia diagnoses made in
England in 2015.1 The burden of chlamydia
is greatest among people aged 15–24 years
where the highest prevalence rates are
found.1 Chlamydia is often asymptomatic
and can pose severe health consequences if
left undiagnosed and/or untreated (ie,
pelvic inﬂammatory disease, infertility,
ectopic pregnancy). Testing and early treat-
ment, therefore, are an effective way to inter-
rupt the transmission chain in the
population and prevent such sequelae.2
Chlamydia testing in general practice
In 2015 (last complete year of sexually trans-
mitted infection surveillance data in
England), a total of 1 538 820 chlamydia tests
were conducted in 15 to 24-year olds;
298 263 (19.4%) of these were performed in
general practice.1 The test positivity (number
of positive tests divided by total number of
tests) in general practice is slightly lower
than the average for all tests in young
people, ∼5.9% versus 8.3%, respectively.1
This indicates that testing in general practice
reaches a slightly different risk group com-
pared to specialist settings. Additionally,
many more young people attend general
practice compared to sexual health clinics
over the course of a year. Hence, there is
considerable potential to reach more young
people with testing in general practice com-
pared to other settings. In the UK, STI
testing is funded by local authorities (local
government) and there is currently a drive to
shift high volume, low cost testing (ie, chla-
mydia testing in asymptomatic young people)
away from expensive specialist settings and
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into primary care (eg, general practice).3 This would
free up capacity in specialist settings to see more
complex patients and put the onus on general practice
to do more testing in asymptomatic young people.
General practice is one logical setting for chlamydia
testing for a variety of reasons. Over 60% of young
people attend general practice annually.4 5 Young
people have reported a preference to receive testing and
testing results from a general practitioner.6–9 Higher
rates of positivity have been found, particularly for men,
in general practice compared to non-healthcare settings
such as universities.3 10 Finally, regular screening is
easier to maintain in this setting, due to patients attend-
ing for other reasons, which is necessary for continued
transmission reduction.10
Barriers and facilitators to chlamydia testing
Annual testing for sexually active young people is recom-
mended in several countries including Australia,
Denmark, England, Norway, Sweden and the USA.11–15
Unfortunately, however, many of those at risk do not
receive testing. Lack of testing has been attributed to
barriers at the patient level, provider level and system
level. In a recent narrative review of chlamydia testing in
general practice, the most common barriers identiﬁed
were the social context of testing (ie, stigma), poor
knowledge/training and time constraints.16 However,
the review was conducted using a narrative approach,
and thus lacks the rigorous methodological techniques
of the systematic review. It is possible that potentially
relevant studies were missed.
To overcome the barriers to testing and exploring the
facilitators, numerous interventions using a variety of
strategies have been conducted.17 18 The evidence for
their effectiveness is mixed. For those that have been
reported as being effective, the effects tend to be
modest,19 20 or demonstrate little clinical signiﬁcance.21
One possible explanation for these disappointing results
is the lack of input from theories of behaviour.
The role of theory
It is increasingly recognised that an understanding of
behaviour and behaviour change is required to maxi-
mise the effectiveness of interventions.22 23 Essentially, in
order to change a particular behaviour (such as increase
chlamydia testing), it is necessary to have a theoretical
understanding of that behaviour.24 25 Applying theory to
intervention design allows researchers to explain and
predict speciﬁc behaviours in terms of why, when and
how they occur, as well as which factors should be tar-
geted in order to alter them. There are numerous theor-
ies of behaviour and it is unclear which one to choose.
A further issue is that, once a suitable theory is identi-
ﬁed, it can be difﬁcult to decipher how to apply it to the
development of an intervention.26
One promising overarching theory of behaviour, and
basis for designing interventions aimed at behaviour
change, is the Capability, Opportunity, Motivation,
Behaviour (COM-B model).27 The COM-B model pro-
poses that behaviour (B) is the result of an interaction
between three components: capability (C), opportunity
(O) and motivation (M). Behaviour change, therefore,
requires a change in one or more of these components.
The COM-B model lies at the centre of the Behaviour
Change Wheel (a tool kit for designing behaviour
change interventions,27) and is the starting point of
intervention development. Capability can be psycho-
logical (eg, knowledge) or physical (eg, skills); oppor-
tunity can be social (eg, societal inﬂuences) or physical
(eg, environmental resources); motivation can be auto-
matic (eg, emotion) or reﬂective (eg, underlying beliefs,
intentions25–27). In other words, for a person to engage
in a speciﬁc behaviour, they need to: (1) be psychologic-
ally and physically able to do the behaviour; (2) have the
physical and social opportunity to do the behaviour; and
(3) want or need to do the behaviour. The model is illu-
strated in ﬁgure 1.
The COM-B model has not yet been applied to chla-
mydia testing; however, it has been successfully applied
in other health behaviour contexts,28–35 and has been
used as basis for developing effective interventions.36–39
The beneﬁt of employing the COM-B model to chla-
mydia testing is that several distinct explanatory compo-
nents are outlined; thus, additional potential inﬂuences
on behaviour can be considered which is essential for
the development of an intervention. Furthermore, once
the COM-B model has been used to conduct an
in-depth theoretically-based analysis of the behaviour in
question, it can be ultimately used to identify the media-
tors and moderators of behaviour to be targeted by an
intervention with the Behaviour Change Wheel.26
Research aims
The aim of this systematic review is to identify the bar-
riers and facilitators to chlamydia testing for young
people in general practice and to use the COM-B model
to conduct a behavioural analysis of chlamydia testing.
The speciﬁc research questions of this systematic review
are:
1. What are the facilitators and barriers to chlamydia
testing for young people in general practice?
Figure 1 The COM-B Model.26
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2. What are the facilitators and barriers to chlamydia
testing for primary care providers in general
practice?
3. How do identiﬁed facilitators and barriers of chla-
mydia testing for young people in general practice
map on to a theoretical model of behaviour change?
4. How do identiﬁed facilitators and barriers of chla-
mydia testing for primary care providers in general
practice map on to a theoretical model of behaviour
change?
METHODS AND ANALYSIS
This systematic review will be conducted in accordance
with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) Statement guide-
lines.40 The PRISMA-Protocol checklist is presented in
online supplementary appendix 1. In addition, the rele-
vant literature for reporting of qualitative studies within
systematic reviews will be consulted to ensure that all
necessary information is provided.41 42 This review is regis-
tered with the international database of prospectively regis-
tered systematic reviews in health and social care
(PROSPERO; registration number CRD42016041786; avail-
able at http://www.crd.york.ac.uk/PROSPERO/display_
record.asp?ID=CRD42016041786).
Eligibility criteria
To be included in the review, papers will have to meet
the following Population, Intervention, Context,
Outcomes and Study design elements:
Population
Inclusion criteria:
Young men and women (aged 15–24 years) and
primary care providers (general practitioners, practice
nurses, nurse practitioners).
Exclusion criteria:
Studies focusing exclusively on commercial sex
workers, incarcerated people, people living with HIV,
victims of sexual or domestic abuse or violence, intra-
venous drug users and individuals with no ﬁxed
address as these groups have distinct needs beyond
the scope of the review. Studies which partially include
these populations (ie, as part of a general population
sample) will be included; however, the sample com-
position will be discussed when interpreting their
ﬁndings.
Intervention
The issue to be reviewed is opportunistic and systematic
chlamydia testing for young people in general practice.
Opportunistic testing will be deﬁned as the offer of a
diagnostic test to people attending general practice
during a consultation for another reason. Systematic
testing will be deﬁned by the use of existing population
registers to invite the target group to submit self-
collected samples by post. A barrier will be deﬁned as a
factor that obstructs or prevents chlamydia testing; a
facilitator will be deﬁned as a factor that supports or
promotes chlamydia testing.
Inclusion criteria:
Randomised and non-randomised controlled trials,
pretest and post-test designs, non-experiment observa-
tional (cross-sectional, case-series, case studies) and
qualitative papers (interviews, focus groups).
Exclusion criteria:
Exclusively set outside of general practice, exclusively
focused on partner notiﬁcation, campaigns exclusively
focused on health promotion, and testing for diagnos-
tic purposes when symptoms are present.
Context
Inclusion criteria:
Studies conducted in Australia, Denmark, Ireland, the
Netherlands, New Zealand and the UK as the model of
delivering healthcare in general practice is comparable.
Exclusion criteria:
Studies conducted in countries where the general
practice setting is not comparable to that of the UK
(eg, the USA, Canada).
Outcomes
Primary outcomes
▸ Young people: Perceived facilitators to chlamydia
testing, perceived barriers to chlamydia testing, views
towards chlamydia testing and acceptability of chla-
mydia testing.
▸ Primary care providers: Perceived facilitators to chla-
mydia testing, perceived barriers to chlamydia testing,
views towards chlamydia testing and acceptability of
chlamydia testing.
Secondary outcomes
Classiﬁcation of the identiﬁed barriers and facilitators
into the subcomponents of the COM-B model: psycho-
logical capability, physical capability, social opportun-
ity, physical opportunity, automatic motivation and
reﬂective motivation..
Study design
Inclusion criteria:
Quantitative (ie, cross-sectional, case-series and case
studies), qualitative and mixed method studies.
Exclusion criteria:
Commentary or opinion publications that do not
present new data.
Information sources
The review will access both published and unpublished
material by searching literature sources listed below
between January 2000 and March 2016. Pre-2000 studies
will be excluded as Nucleic Acid Ampliﬁcation Tests of
urine samples were introduced around this time, thus
widening testing to non-clinical settings. The following
databases will be searched: MEDLINE, PubMed,
EMBASE, Informit, Web of Science, PsycINFO and
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Scopus. Relevant articles will also be identiﬁed from a
manual search of reference lists of included articles.
Search strategy
Medical Subject Headings (MeSH), subject headings
and keywords will be created by using language that
describes facilitators and barriers to chlamydia testing in
general practice. Boolean combinations will create more
speciﬁc searches. Initial scoping searches will be con-
ducted to reﬁne the search strategy. For example, key
publications in the ﬁeld will be identiﬁed and searches
run to ensure that these are captured. The three sets of
search terms relate to the context (general practice),
the intervention (chlamydia testing) and outcomes (bar-
riers and facilitators). The search strategy presented in
online supplementary appendix 2 will be used to search
MEDLINE, using an Ovid platform. Search terms pertain-
ing to behaviour and behaviour change theories which
will be piloted are presented in online supplementary
appendix 3. Search terms will be modiﬁed for other data-
bases where subject heading indexing differs from the
terms used in MEDLINE.
Data extraction and management
Data will be extracted from all full-text studies that fulﬁl
the inclusion criteria. The reviewers will characterise the
research design used in each study, including study popu-
lation, sample size, response rate (if described), random-
isation (if randomised controlled trial), presence or
absence of a comparison group, data collection methods
and key ﬁndings (primary/secondary outcomes).
A standardised framework will be devised and used to
record the aims, methodological characteristics, main
ﬁndings and relevance of each study. All identiﬁed refer-
ences will be stored in Endnote. Data extraction will be
undertaken by one reviewer (LMD) and checked by a
second reviewer (HB/TH). Any discrepancies will be
resolved by discussion between two researchers or adju-
dication by a third reviewer (GR/JC) when necessary.
If required, primary authors will be contacted for
additional data.
All studies that meet the inclusion criteria will be
described in terms of:
▸ Design and quality, data collection methods, modes
and techniques; validity of tools; qualitative, statistical
and other analyses
▸ Participants, demographic characteristics (eg, age,
ethnicity)
▸ Setting and recruitment methods, details of modes of
delivery and any other aspects of content
▸ Theoretical framework employed in study (if any)
The following data will be extracted:
1. Data relating to young people:
▸ Perceived facilitators to chlamydia testing, per-
ceived barriers to chlamydia testing, reasons for
accepting or refusing the offer of chlamydia
testing and acceptability of chlamydia testing in
general practice.
2. Data relating to primary care providers:
▸ Perceived facilitators to chlamydia testing, per-
ceived barriers to chlamydia testing, provider
reasons for providing chlamydia testing to young
people and acceptability of chlamydia testing in
general practice.
Risk of bias (quality) assessment
The quality of each paper will be assessed independently
by two reviewers (LMD and HB/TH). Any discrepancies
will be resolved by consensus and, if necessary, a third
party will be consulted. Each paper will be assessed using
criteria based on the Critical Appraisal Skills
Programme.43 Individual studies will be classiﬁed as
primary (high-quality studies providing theoretical insight
into sexual behaviour or thorough descriptions of particu-
lar contexts) and secondary (lower quality studies that
had simple, non-detailed descriptions or do not support
statements with evidence). The critical appraisal process
will not be used to exclude papers prior to the synthesis;
rather, it will be used to provide a context for the inter-
pretation of the synthesised ﬁndings.
Data synthesis and analysis
Individual study characteristics and outcomes will be
summarised and presented in an evidence table.
Thematic analysis, employing expert guidelines,44 will be
used to identify prominent/recurrent themes in the lit-
erature. The use of the statistical software package
NVivoV.11 will aid in managing the coding of the data
set, with each code (or node) representing the emer-
gent themes, for example, ‘education’. The frequency of
themes as well as their explanatory value will be assessed.
The themes will be reﬁned through discussion and the
use of constant comparison within and between codes to
ensure that they accurately reﬂect the material.
Finally, a behavioural analysis of chlamydia testing
behaviour will be conducted. Speciﬁcally, the identiﬁed
themes will be classiﬁed into the six subcomponents of
the COM-B model (psychological capability, physical
capability, social opportunity, physical opportunity, auto-
matic motivation and reﬂective motivation; see ﬁgure 1).
Data classiﬁcation will be conducted by one reviewer
(LMD) in consultation with members of the review team
( JS, JC, HB, TH and GR), employing guidelines set out
by Michie and colleagues.27 Any discrepancies will be
resolved by consensus.
DISCUSSION AND DISSEMINATION
To the best of the authors’ knowledge, this is the ﬁrst sys-
tematic review to conduct a theoretical behavioural ana-
lysis of barriers and facilitators to chlamydia testing for
young people in general practice. A theoretically based
framework will be generated which will provide a greater
insight into the complexities of chlamydia testing. The
ﬁndings will have relevance to healthcare professionals,
policymakers and commissioners in informing how best
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to improve the sexual health of young people.
Importantly, the results will be integral to inform the
development of interventions that will facilitate effective
and efﬁcient access to care and treatment for chlamydia
in primary care, with the aim of reducing morbidity and
transmission of chlamydia.
The review results will be disseminated via submission
for publication to a peer-review journal when complete
and submissions to be presented at national and inter-
national conferences (where eligible). Furthermore, lay
and scientiﬁc summaries will be produced for wider dis-
semination (eg, via newsletters, blogs and organisation
meetings).
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